EU approves Takeda buying Shire, on divestment condition

The European Commission said on Tuesday that it approved the $62-billion takeover of London’s Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.

…read more

Source:: Reuters – Business News


Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.